Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CERS – Cerus Corporation

Cerus Corporation
CERS
$2.06
Name : Cerus Corporation
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $395,700,256.00
EPSttm : -0.08
finviz dynamic chart for CERS
Cerus Corporation
$2.06
1.44%
$0.03

Float Short %

3.41

Margin Of Safety %

-33

Put/Call OI Ratio

0.12

EPS Next Q Diff

EPS Last/This Y

0.03

EPS This/Next Y

0.05

Price

2.05

Target Price

4.67

Analyst Recom

1.5

Performance Q

35.53

Relative Volume

0.7

Beta

1.54

Ticker: CERS




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-02CERS1.880.060.028373
2025-12-03CERS1.990.060.008406
2025-12-04CERS2.10.060.008317
2025-12-05CERS2.060.060.008101
2025-12-08CERS1.870.060.008083
2025-12-09CERS1.850.060.008088
2025-12-10CERS1.90.060.008086
2025-12-11CERS2.160.060.008086
2025-12-12CERS2.180.060.008022
2025-12-15CERS2.020.060.067941
2025-12-16CERS2.160.060.027898
2025-12-17CERS2.190.060.007769
2025-12-18CERS2.160.060.017702
2025-12-19CERS2.080.060.137672
2025-12-22CERS2.110.060.053844
2025-12-23CERS2.050.06999.993887
2025-12-26CERS2.040.06999.993887
2025-12-29CERS2.060.060.003890
2025-12-30CERS2.080.062.223896
2025-12-31CERS2.050.120.004106
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-02CERS1.8750.0- -0.08
2025-12-03CERS1.9950.0- -0.08
2025-12-04CERS2.1150.0- -0.08
2025-12-05CERS2.0750.0- -0.08
2025-12-08CERS1.8750.0- -0.08
2025-12-09CERS1.8650.0- -0.08
2025-12-10CERS1.8650.0- -0.08
2025-12-11CERS2.1550.0- -0.08
2025-12-12CERS2.1850.0- -0.08
2025-12-15CERS2.0150.0- -0.08
2025-12-16CERS2.0150.0- -0.08
2025-12-17CERS2.1950.0- -0.08
2025-12-18CERS2.1650.0- -0.08
2025-12-19CERS2.0850.0- -0.08
2025-12-22CERS2.1450.0- -0.08
2025-12-23CERS2.0550.0- -0.08
2025-12-26CERS2.0350.0- -0.08
2025-12-29CERS2.0650.0- -0.08
2025-12-30CERS2.0850.0- -0.08
2025-12-31CERS2.0550.0- -0.08
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-02CERS-0.32-0.123.13
2025-12-03CERS-0.32-0.123.13
2025-12-04CERS-0.32-0.123.13
2025-12-05CERS-0.32-0.123.13
2025-12-08CERS-0.32-0.273.13
2025-12-09CERS-0.32-0.273.13
2025-12-10CERS-0.32-0.273.19
2025-12-11CERS-0.32-0.273.19
2025-12-12CERS-0.32-0.273.19
2025-12-15CERS-0.32-0.273.19
2025-12-16CERS-0.32-0.273.19
2025-12-17CERS-0.32-0.273.19
2025-12-18CERS-0.32-0.273.19
2025-12-19CERS-0.32-0.273.19
2025-12-22CERS-0.32-0.273.19
2025-12-23CERS-0.32-0.273.19
2025-12-26CERS-0.32-0.273.41
2025-12-29CERS-0.32-0.273.41
2025-12-30CERS-0.32-0.273.41
2025-12-31CERS-0.32-0.273.41
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.01

Avg. EPS Est. Next Quarter

-0.03

Insider Transactions

-0.32

Institutional Transactions

-0.27

Beta

1.54

Average Sales Estimate Current Quarter

59

Average Sales Estimate Next Quarter

51

Fair Value

1.38

Quality Score

42

Growth Score

51

Sentiment Score

88

Actual DrawDown %

75.6

Max Drawdown 5-Year %

-85.4

Target Price

4.67

P/E

Forward P/E

PEG

P/S

1.99

P/B

6.44

P/Free Cash Flow

2327.63

EPS

-0.08

Average EPS Est. Cur. Y​

-0.08

EPS Next Y. (Est.)

-0.03

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-8.01

Relative Volume

0.7

Return on Equity vs Sector %

-53.3

Return on Equity vs Industry %

-43.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Cerus Corporation
Sector: Healthcare
Industry: Medical Devices
Employees: 614
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
stock quote shares CERS – Cerus Corporation Stock Price stock today
news today CERS – Cerus Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch CERS – Cerus Corporation yahoo finance google finance
stock history CERS – Cerus Corporation invest stock market
stock prices CERS premarket after hours
ticker CERS fair value insiders trading